Cannabis Industry Offers Good Fit for Medical Device Technology Provider Therma Bright, Inc. (TSX.V: THRM) (OTC: THRBF)

December 7, 2018 11:04:45
  • Therma Bright to establish subsidiary to hold pain relief device-related technology and intellectual property developed for application/use of cannabis formulations
  • Therma Bright portfolio currently includes products, devices and treatments offering cosmetic, medicinal or therapeutic benefits for effective, non-invasive, pain-free skin care for cold sores, insect and marine life bites
  • Proprietary thermal therapy device technology has received Class II medical device status from the U.S. Food and Drug Administration
  • Legal cannabis market expected to reach $146.5 billion by end of 2025 with CAGR of 34 percent

Therma Bright, Inc. (TSX.V: THRM) (OTC: THRBF) continues to develop a new pain relief device that incorporates the company’s thermal therapy technology with medical grade cannabis or cannabidiol (CBD) sourced from hemp as a cream or gel to provide relief of back, knee and other joint pain. A wholly owned subsidiary is being incorporated to hold any device or technology that Therma Bright develops for use or application of cannabis, the company announced in a news release (

Therma Bright will conduct all research and handling of any medicinal cannabis through authorized and licensed research facilities…

Read More>>

  • Based on double blind placebo study, InterceptCS™ is approved for the claim “For prevention of cold sores when used within 3 hours of the onset of the prodrome.” by Health Canada. InterceptCS™ is not approved by the United States FDA for any claim of clinical indication, clinical efficacy and/or cure or prevention of disease.

More from NetworkNewsWire

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive instant SMS alerts, text STOCKS to 77948

For more information, please visit

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published:

NetworkNewsWire (NNW)
New York, New York
212.418.1217 Office